Chronic bacterial prostatitis (NIH type II): Diagnosis, therapy and influence on the fertility status

Andrologia

Volumn 40, Issue 2, 2008, Pages 100-104

  Wagenlehner, F M E ^a   Diemer, T ^a   Naber, K G ^b   Weidner, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacterial prostatitis; Fluoroquinolones; Infertility; Management; NIH classification

Indexed keywords

CIPROFLOXACIN; ENOXACIN; FLEROXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; CHRONIC PROSTATITIS; CONFERENCE PAPER; DIAGNOSTIC TEST; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG INDICATION; DRUG PENETRATION; FOLLOW UP; FOUR GLASS TEST; GRAM NEGATIVE BACTERIUM; HUMAN; MALE; MALE INFERTILITY; PELVIS PAIN SYNDROME; REINFECTION; RELAPSE; SEMINAL PLASMA; SYMPTOM; TWO GLASS TEST;

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; HUMANS; INFERTILITY, MALE; MALE; PROSTATITIS;

EID: 40749112320     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2007.00827.x     Document Type: Conference Paper

References (36)

1. Barbalias GA, Nikiforidis G, Liatsikos EN (1998) Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 159 : 883 887.
2. Bulitta J, Kinzig-Schippers M, Naber CK, Naber KG, Sauber S, Kleinschnitz M, Wahode H, Rodamer M, Sörgel F (2000) Limitations in the use of drug cocktails to compare the pharmacokinetics of drugs: ciprofloxacin vs levofloxacin. Antimicrob Agents Chemother 40 : 18.
3. Bundrick W, Heron SP, Ray P, Schiff WM, Tennenberg AM, Wiesinger BA, Wright PA, Wu SC, Zadeikis N, Kahn JB (2003) Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology 62 : 537 541.
4. Clemens J, O'Keeffe-Rosetti M, Gao SY, Calhoun EA (2005) Incidence and clinical characteristics of NIH Type III prostatitis in a managed care population. American Urological Association Annual Meeting, San Antonio.
5. Diemer T, Huwe P, Ludwig M, Schroeder-Printzen I, Michelmann HW, Schiefer HG, Weidner W (2003) Influence of autogenous leucocytes and Escherichia coli on sperm motility parameters in vitro. Andrologia 35 : 100 105.
6. Farker K, Naber KG, Fünfstück R (2001) Fluoroquinolones: utilization in renal and urogenital tract infections. Med Klin (Munich) 96 : 383 390.
7. Gasser T, Larsen EH, Dorflinger T, Madsen PO (1986) The influence of various body fluids and pH on E. coli MIC of quinolone derivatives. In : Therapy of Prostatitis Experimental and Clinical Data. Weidner W (ed). Zuckschwerdt, Munich, pp 50 53.
8. Krieger JN, McGonagle LA (1989) Diagnostic considerations and interpretation of microbiological findings for evaluation of chronic prostatitis. J Clin Microbiol 27 : 2240 2244.
9. Krieger JN, Nyberg L, Jr., Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282 : 236 237.
10. Meares EM, Stamey TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5 : 492 518.
11. Naber K (1993) Role of quinolones in treatment of chronic bacterial prostatitis. In : Quinolone Antimicrobial Agents. Hooper WJ (ed). American Society of Microbiology, Washington, pp 285 297.
12. Naber KG (2002) Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents 20 : 18 27.
13. Naber KG, Giamarellou H (1994) Proposed study design in prostatitis. Infection 22 (Suppl 1 S59 S60.
14. Naber KG, Sörgel F (2003) Antibiotic therapy - rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 35 : 331 335.
15. Naber KG, Kinzig M, Sörgel F, Weigel D (1993a) Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid. Infection 21 : 98 100.
16. Naber KG, Sorgel F, Kinzig M, Weigel DM (1993b) Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg. J Urol 150 : 1718 1721.
17. Naber KG, Busch W, Focht J (2000) Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int J Antimicrob Agents 14 : 143 149.
18. Naber CK, Steghafner M, Kinzig-Schippers M, Sauber C, Sörgel F, Stahlberg HJ, Naber KG (2001a) Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers. Antimicrob Agents Chemother 45 : 293 297.
19. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi FP (2001b) EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 40 : 576 588.
20. Nickel JC, Olson ME, Costerton JW (1991) Rat model of experimental bacterial prostatitis. Infection 19 (Suppl 3 S126 S130.
21. Nickel JCZN, Spivey M, Wu SC (2005) Clinical significance of antimicrobial therapy in chronic prostatitis associated with non-traditional uropathogens. American Urological Association Annual Meeting, San Antonio.
22. Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE, Jr., Zeitlin S, O'Leary MP, Pontari MA, Schaeffer AJ, Landis JR, Nyberg L, Kusek JW, Propert KJ (2006) How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol 176 : 119 124.
23. Pfau A (1991) The treatment of chronic bacterial prostatitis. Infection 19 (Suppl 3 S160 S164.
24. Pust RA, Ackenheil-Koppe HR, Gilbert P, Weidner W (1989) Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results. J Chemother (Suppl.) 4 : 869 871.
25. Riley DERS, Limaye AP, Krieger JN (2005) Inconsistent localization of Gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis. American Urological Association Annual Meeting, San Antonio.
26. Ruiz J, Simon K, Horcajada JP, Velasco M, Barrano M, Roig G, Moreno-Martinez A, Martinez JA, Jimenez De Anta T, Mensa J, Vila J (2002) Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 40 : 4445 4449.
27. Schaeffer AJ (1999) Prostatitis: US perspective. Int J Antimicrob Agents 11 : 205 211.
28. Schaeffer AJ, Darras FS (1990) The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim- sulfamethoxazole and/or carbenicillin. J Urol 144 : 690 693.
29. Sörgel F, Kinzig M, Naber KG (1993) Physiological disposition of macrolides. In : Macrolides: Chemistry, Pharmacology and Clinical Uses. Bryskier A, Butzler JP, Neu HC, Tulkens PM (eds). Arnette Blackwell, Paris, pp 421 431.
30. Sörgel F, Bulitta J, Kinzig-Schippers M (2002) Pharmakokinetik der Chinolone. Chemother J 11 (Suppl. 20 25 33.
31. Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J (2007) Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177 : 365 368.
32. Stamey TA, Meares EM, Jr., Winningham DG (1970) Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol 103 : 187 194.
33. Weidner W, Schiefer HG, Dalhoff A (1987) Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study. Am J Med 82 : 280 283.
34. Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M (1991a) Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1461 patients. Infection 19 (Suppl 3 S119 S125.
35. Weidner W, Schiefer HG, Brähler E (1991b) Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol 146 : 350 352.
36. Weidner W, Ludwig M, Brahler E, Schiefer HG (1999) Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs 58 (Suppl 2 103 106.